Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -0.231M
June 30, 2026 0.00
March 31, 2026 -0.066M
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 10.40M
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
Date Value
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 -0.007M
June 30, 2021 0.002M
March 31, 2021 1.462M
December 31, 2020 1.436M
September 30, 2020 0.003M
June 30, 2020 -0.065M
March 31, 2020 -1.356M
December 31, 2019 -0.10M
September 30, 2019 -0.554M
June 30, 2019 -4.247M
March 31, 2019 -1.814M
December 31, 2018 -1.816M
September 30, 2018 -1.16M
June 30, 2018 -0.30M
March 31, 2018 -0.162M
December 31, 2017 -0.436M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. -0.052M
IRulya Therapeutics, Inc. -67.79M
Climb Bio, Inc. 6.40M
PepGen Inc. 12.46M
Bridgebio Oncology Therapeutics, Inc. 50.34M